News & Updates

Treatment with trastuzumab emtansine (T-DM1) plus tucatinib safely prolongs progression-free survival (PFS) in patients with previously treated HER2-positive locally advanced (LA) or metastatic breast cancer (MBC), including those with brain metastases, reports a study.

Breast cancer survivors who have adequate sleep achieve greater benefits from behavioural weight loss (BWL) intervention than those with poor sleep, according to the results from the POWER-Remote trial.

Never smokers with selected risk factors who undergo lung cancer screening may show similar detection rates to high-risk ever smokers or even higher rates when compared with unselected never smokers, reveals a Singapore study.

A randomized, double-blind, placebo-controlled trial from Iran reports a significant reduction in frequency of mild hot flushes with use of melatonin in patients with prostate cancer (PC) undergoing androgen deprivation therapy (ADT).

Plasma circulating tumour DNA (ctDNA) can act as a biomarker for the early detection of metastatic progression in patients with muscle-invasive bladder cancer (MIBC) treated with bladder-sparing trimodality therapy (TMT), suggests a study.